1 Experiments were performed to investigate the role of endogenously r
eleased tachykinins in the regulation of blood flow to the rat knee jo
int. Synovial perfusion was assessed by laser Doppler perfusion imagin
g, which permitted spatial measurement of relative changes in perfusio
n from control (pre drug administration), expressed as the percentage
change. Most experiments were performed on the exposed medial aspect o
f the knee joint capsule. 2 Neither the selective tachykinin NK1 recep
tor antagonist, FK888, nor the selective tachykinin NK2 receptor antag
onist, SR48968, significantly influenced synovial blood flow at doses
of 10(-12), 10(-10) and 10(-8) mol. However, topical co-administration
of these agents produced significant dose-dependent reductions in bas
al synovial perfusion of 6.3 +/- 4.6, 12.0 +/- 3.4 and 19.9 +/- 2.6%,
respectively; n = 29. The non-selective tachykinin NK1/NK2 receptor an
tagonist, FK224, also produced significant (at 10(-10) and 10(-8) mol)
, but less potent. reductions in perfusion of 5.3 +/- 4.0, 8.4 +/- 2.2
and 5.9 +/- 2.8%, respectively; n = 25. 3 Topical administration of t
he alpha(1)-, alpha(2)-adrenoceptor antagonist phenoxybenzamine elicit
ed 31.3 +/- 6.2% increase in blood flow which was substantially reduce
d to 10.4 +/- 3.8% by co-administration of the FK888 and SR48968 (both
at 10(-8) mol; n = 8-13), suggesting that normally there is sympathet
ic vasoconstrictor 'tone' which is opposed by the vasodilator action o
f endogenous tachykinins. 4 One week after surgical interruption of th
e nerve supply to the knee joint, co-administration of FK888 and SR489
68 (both at 10(-8) mol) now produced slight vasodilatation (6.7 +/- 4.
6%; n = 9) which did not differ significantly from vehicle treatment.
Depletion of tachykinins from sensory nerve fibres by systemic capsaic
in administration also resulted in abolition of the vasoconstrictor ef
fect of FK888 and SR48968 (both at 10(-8) mol), with these agents only
producing a slight vasodilatation (2.5 +/- 5.3%; n = 6). 5 By use of
a near infra-red laser source it was possible to image knee joint perf
usion transcutaneously, the overlying skin being left intact. In this
more physiological situation, close intra-arterial injection of the co
mbination of FK888 and SR48968 (both at 10(-8) mol) again elicited vas
oconstriction (48.8 +/- 16.2% reduction in blood flow; n = 4). 6 These
results indicate that endogenous tachykinins may be continuously rele
ased from sensory fibres innervating the joint. Basal release of tachy
kinins could therefore be an important physiological influence opposin
g sympathetic vasoconstrictor tone.